5-chloro-N2-(4-((2-(dimethylamino)ethyl)(methyl)amino)-2-methoxyphenyl)-N4-(2-(ethylsulfinyl)-4-fluorophenyl)pyrimidine-2,4-diamine

ID: ALA4877409

PubChem CID: 164627272

Max Phase: Preclinical

Molecular Formula: C24H30ClFN6O2S

Molecular Weight: 521.06

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC[S+]([O-])c1cc(F)ccc1Nc1nc(Nc2ccc(N(C)CCN(C)C)cc2OC)ncc1Cl

Standard InChI:  InChI=1S/C24H30ClFN6O2S/c1-6-35(33)22-13-16(26)7-9-20(22)28-23-18(25)15-27-24(30-23)29-19-10-8-17(14-21(19)34-5)32(4)12-11-31(2)3/h7-10,13-15H,6,11-12H2,1-5H3,(H2,27,28,29,30)

Standard InChI Key:  VLAHZAGOOADEEK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 37  0  0  0  0  0  0  0  0999 V2000
   40.9784   -4.6958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9772   -5.5233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6920   -5.9362    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.4084   -5.5228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4056   -4.6922    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.6902   -4.2831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2638   -4.2835    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   41.6877   -3.4581    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.9720   -3.0477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9729   -2.2235    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2580   -1.8132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5439   -2.2278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5489   -3.0571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.2644   -3.4636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6871   -1.8105    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   42.4019   -2.2224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6865   -0.9854    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.1236   -5.9342    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   45.2638   -7.1698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.1249   -6.7592    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4097   -7.1712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4107   -7.9955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.1263   -8.4077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.8425   -7.9896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.8381   -7.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.5505   -6.7507    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.1160   -1.8094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.1288   -9.2327    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.4155   -9.6473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.8444   -9.6431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.8468  -10.4681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.5625  -10.8785    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.5649  -11.7036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2758  -10.4640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8276   -1.8184    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 10 15  1  0
 15 16  1  0
 15 17  1  0
  4 18  1  0
 26 19  1  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 25 26  1  0
 16 27  1  0
 23 28  1  0
 28 29  1  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  1  0
 12 35  1  0
M  CHG  2  15   1  17  -1
M  END

Alternative Forms

  1. Parent:

    ALA4877409

    ---

Associated Targets(Human)

NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 521.06Molecular Weight (Monoisotopic): 520.1824AlogP: 4.89#Rotatable Bonds: 11
Polar Surface Area: 88.61Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.21CX Basic pKa: 8.93CX LogP: 4.16CX LogD: 2.63
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.35Np Likeness Score: -1.44

References

1. Wu F, Yao H, Li W, Zhang N, Fan Y, Chan ASC, Li X, An B..  (2021)  Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing a sulfoxide moiety as anaplastic lymphoma kinase (ALK) inhibition agents.,  48  [PMID:34245852] [10.1016/j.bmcl.2021.128253]

Source